deferoxamine has been researched along with Cranial Nerve II Injuries in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Also, since DFO is poor in bioavailability and of very short half-life in vivo, its safe and efficient intravitreal delivery is critical." | 1.72 | Efficiently suppress of ferroptosis using deferoxamine nanoparticles as a new method for retinal ganglion cell protection after traumatic optic neuropathy. ( Gao, W; Huang, B; Lin, S; Lou, Q; Mehmood, R; Nan, K; Ren, Y; Ye, C; Zhu, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, S | 1 |
| Gao, W | 1 |
| Zhu, C | 1 |
| Lou, Q | 1 |
| Ye, C | 1 |
| Ren, Y | 1 |
| Mehmood, R | 1 |
| Huang, B | 1 |
| Nan, K | 1 |
1 other study available for deferoxamine and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Efficiently suppress of ferroptosis using deferoxamine nanoparticles as a new method for retinal ganglion cell protection after traumatic optic neuropathy.
Topics: Animals; Cyclooxygenase 2; Deferoxamine; Ferroptosis; Iron; Nanoparticles; Optic Nerve Injuries; Rat | 2022 |